Results of Analysis of the OASIS Study,a Large-Scale Health-Related QOL Study in Patients with Chronic Cerebral Infarction
February 21, 2008
Having completed the OASIS Study, Japan's first large-scale study with respect to health-related quality of life (below, "health-related QOL") in Chronic Cerebral Infarction , Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Ikuo Ogihara), a subsidiary of Kyorin Co., Ltd., presented the study results at the International Stroke Conference 2008 at New Orleans, Louisiana, USA on February 20 local time.
